More on IMNM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $17.40 |
|
|||
| Open | $17.40 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $17.40 | ||||
| Day Low | $16.41 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,299,729 | ||||
- William Blair Starts Immunome Inc. (IMNM) at Outperform
- Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Immunome (IMNM) Reiterated at Hold by Stifel on Sensible License Cleanup With Bristol
- Form 8-K Immunome Inc. For: Oct 02
- Stifel Starts Immunome Inc. (IMNM) at Hold
- FDA clears Immunome IND for IM-1340 solid tumor antibody-drug conjugate
- Immunome Announces IND Clearance for IM-1340, a Potential First-in-Class Antibody-Drug Conjugate for the Treatment of Solid Tumors
- Alliance Global Partners Starts Immunome Inc. (IMNM) at Buy
- Form 4 Immunome Inc. For: Sep 11 Filed by: Higgins Jack
- Form 144 Immunome Inc. Filed by: Higgins Jack
Entities mentioned with IMNM
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- Show More...
